Literature DB >> 1721358

The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation.

J M Armitage1, R L Kormos, J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721358      PMCID： PMC2978532     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

Authors:  J J Fung; S Todo; A Jain; J McCauley; M Alessiani; C Scotti; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Early trials with FK 506 as primary treatment in liver transplantation.

Authors:  S Todo; J J Fung; A J Demetris; A Jain; R Venkataramanan; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

5.  Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin.

Authors:  R L Kormos; J M Armitage; J S Dummer; Y Miyamoto; B P Griffith; R L Hardesty
Journal:  Transplantation       Date:  1990-02       Impact factor: 4.939

6.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889
  6 in total
  14 in total

1.  Vasorelaxation and inhibition of the voltage-operated Ca2+ channels by FK506 in the porcine coronary artery.

Authors:  T Yasutsune; N Kawakami; K Hirano; J Nishimura; H Yasui; K Kitamura; H Kanaide
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Fluconazole therapy in transplant recipients receiving FK506.

Authors:  R Mañez; M Martin; D Raman; D Silverman; A Jain; V Warty; I Gonzalez-Pinto; S Kusne; T E Starzl
Journal:  Transplantation       Date:  1994-05-27       Impact factor: 4.939

4.  Effect of the immunosupressant FK506 on excitation-contraction coupling and outward K+ currents in rat ventricular myocytes.

Authors:  W H duBell; P A Wright; W J Lederer; T B Rogers
Journal:  J Physiol       Date:  1997-06-15       Impact factor: 5.182

Review 5.  Heart transplantation: approaching a new century.

Authors:  B Radovancević; O H Frazier
Journal:  Tex Heart Inst J       Date:  1999

6.  Tacrolimus in pediatric renal transplantation.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

7.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994

8.  Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.

Authors:  László Szabó; Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Ferenc Ruzsnavszky; Krisztina Váczi; Balázs Horváth; János Magyar; Tamás Bányász; Balázs Pál; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-19       Impact factor: 3.000

Review 9.  The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; R J Corry; F Egidi; J McCauley; D Ellis; N Gilboa
Journal:  Clin Transpl       Date:  1995

10.  A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

Authors:  R Shapiro; M Jordan; V Scantlebury; C Vivas; J Fung; J McCauley; A Tzakis; P Randhawa; A J Demetris; W Irish
Journal:  Clin Transplant       Date:  1994-12       Impact factor: 2.863
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.